SCHEMBL134081

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL6382767	0.78	ENPP2 (0.50)	TAAR1
	SCHEMBL1767187	0.77	IDO1 (0.69)	IDO1AGXTMAOBMAOAHCAR2
	SCHEMBL9256358	0.77	SOD1 (0.43)	IDO1AGXT
	SCHEMBL95133	0.77	IDO1 (0.58)	IDO1AGXTMAOBMAOAHCAR2
	SCHEMBL5543288	0.77	IDO1 (0.58)	IDO1MAOBMAOA
	SCHEMBL1822739	0.77	IDO1 (0.58)	IDO1MAOBMAOATAAR1MMP2
	SCHEMBL5545771	0.77	MAOB (0.47)	MAOBMAOATHRATHRB
	SCHEMBL95565	0.77	CYP3A4 (0.58)	IDO1AGXTMAOBMAOAHCAR2
	SCHEMBL5540731	0.76	AGXT (0.59)	AGXTMMP1MMP2MMP9MMP12
	SCHEMBL8480	0.75	IDO1 (0.52)	IDO1MAOBMAOATAAR1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.